BETHESDA, Md., April 7 /PRNewswire-USNewswire/ -- The Federation of American Societies for Experimental Biology
"While it is clear the President recognized the importance of investing in biomedical research, based on the 3.2 percent increase he proposed in his FY2011 budget, the supplemental appropriations the agency received in FY2010 has created a wealth of emerging opportunities that cannot be ignored," stated Mark O. Lively, Ph.D., FASEB President, "We want to ensure that policymakers understand that our progress against devastating conditions like cancer and Alzheimer's disease depends on sustaining the momentum of our current enterprise. This is more than just a trend in data; it is symbolic of a diminishment of hope."
FASEB hopes the series of graphs and analysis, which provides information on expenditures for research grants, grant numbers, success rates, and average award sizes, will help policymakers understand the case for sustained funding for biomedical research. To that end, FASEB has recommended that Congress appropriate $37 billion for NIH in FY2011.
To view the FASEB NIH data resource, please visit: http://www.faseb.org/Policy-and-Government-Affairs/Data-Compilations/NIH-Research-Funding-Trends.aspx
FASEB is composed of 23 societies with more than 90,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improve - through their research - the health, well-being, and productivity of all people. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
SOURCE Federation of American Societies for Experimental Biology
Subscribe to our Free Newsletters!